Liraglutide effect and action in diabetes-In (LEAD-In): A prospective observational study assessing safety and effectiveness of liraglutide in patients with type 2 diabetes mellitus treated under routine clinical practice conditions in India

Subhash Kumar Wangnoo; Surender Kumar; Arpandev Bhattacharyya; Sudhir Tripathi; Shahid Akhtar; Raman Shetty; Samit Ghosal

首页> 外文期刊>Indian Journal of Endocrinology and Metabolism >Liraglutide effect and action in diabetes-In (LEAD-In): A prospective observational study assessing safety and effectiveness of liraglutide in patients with type 2 diabetes mellitus treated under routine clinical practice conditions in India

【24h】

Liraglutide effect and action in diabetes-In (LEAD-In): A prospective observational study assessing safety and effectiveness of liraglutide in patients with type 2 diabetes mellitus treated under routine clinical practice conditions in India

机译：利拉鲁肽在糖尿病患者中的作用和作用（LEAD-In）：一项前瞻性观察性研究，评估利拉鲁肽在印度常规临床实践条件下治疗的2型糖尿病患者中的安全性和有效性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Indian Journal of Endocrinology and Metabolism》 |2016年第6期|共8页
作者
Subhash Kumar Wangnoo; Surender Kumar; Arpandev Bhattacharyya; Sudhir Tripathi; Shahid Akhtar; Raman Shetty; Samit Ghosal;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice-EVIDENCE: A Prospective, 2-Year Follow-Up, Observational, Post-Marketing Study [J] . Gautier Jean-Francois, Martinez Luc, Penfornis Alfred, Advances in therapy. . 2015,第9期

机译：常规临床实践中证据表明，利拉鲁肽在2型糖尿病患者中的有效性和持续性：证据：一项为期2年的随访，观察，上市后研究
2. A multicentre, UK, retrospective, observational study to assess the effectiveness of insulin glargine 300 units/ml in treating people with Type 1 diabetes mellitus in routine clinical practice (SPARTA) [J] . Pang T., Bain S. C., Black R. Neil A., Diabetic medicine: A journal of the British Diabetic Association . 2019,第1期

机译：一种多期，英国，回顾性，观察性研究，以评估胰岛素狼犬300单位/ ml在常规临床实践中治疗1型糖尿病患者（Sparta）的糖尿病患者的有效性
3. Liraglutide vs. lixisenatide in obese type 2 diabetes mellitus patients: What effect should we expect in routine clinical practice? [J] . Moreno-Fernandez Jesus, Alberto Garcia-Seco Jose, Seco Segura Angela Maria, Primary care diabetes . 2020,第1期

机译：Liraglutide对肥胖型2型糖尿病患者的Lixisenatide：我们应该在常规临床实践中预期什么效果？
4. Clinical observation of traditional Chinese Baduanjin Qigong (Eight trigrams boxing) in the treatment of patients with type 2 diabetes mellitus [C] . Yunchuan Wu, Feng Hao, Han Yang, International Conference on Information Technology in Medicine and Education . 2018

机译：中国传统的Baduanjin气功（八三胎拳）治疗2型糖尿病患者的临床观察
5. Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice—EVIDENCE: A Prospective 2-Year Follow-Up Observational Post-Marketing Study [O] . Jean-Francois Gautier, Luc Martinez, Alfred Penfornis, -1

机译：常规临床实践中的2型糖尿病患者使用利拉鲁肽的有效性和持续性-证据：一项为期2年的随访观察上市后研究
6. Liraglutide effect and action in diabetes-In (LEAD-In): A prospective observational study assessing safety and effectiveness of liraglutide in patients with type 2 diabetes mellitus treated under routine clinical practice conditions in India [O] . Subhash Kumar Wangnoo, Surender Kumar, Arpandev Bhattacharyya, 2016

机译：利拉鲁肽在糖尿病中的作用和作用-LE（LEaD-In）：一项前瞻性观察性研究，评估利拉鲁肽在印度常规临床实践条件下治疗的2型糖尿病患者的安全性和有效性

Liraglutide effect and action in diabetes-In (LEAD-In): A prospective observational study assessing safety and effectiveness of liraglutide in patients with type 2 diabetes mellitus treated under routine clinical practice conditions in India

著录项

相似文献

相关主题

期刊订阅